Richard R. DeLuca - May 3, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP&Pres, Merck Animal Heallth
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
Stock symbol
MRK
Transactions as of
May 3, 2022
Transactions value $
$0
Form type
4
Date filed
5/5/2022, 05:01 PM
Previous filing
Feb 28, 2022
Next filing
Nov 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 135K May 3, 2022 Direct F1
holding MRK Common Stock - 401(k) Plan 1.17K May 3, 2022 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +58.3K $0.00 58.3K May 3, 2022 Common Stock 58.3K $87.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through April 7, 2022 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.